Prophylactic mastectomy and inherited predisposition to breast carcinoma

Cancer

Volumn 86, Issue 8 SUPPL., 1999, Pages 1682-1696

  Hughes, Kevin S ^a   Papa, Moshe Z ^b   Whitney, Timothy ^a   McLellan, Robert ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

BRCA1; BRCA2; Breast carcinoma; Breast reconstruction; Prophylactic mastectomy

Indexed keywords

BREAST CANCER; BREAST RECONSTRUCTION; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; MASTECTOMY; ONCOGENE; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0033569799     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19991015)86:8+<1682::aid-cncr7>3.0.co;2-6     Document Type: Conference Paper

References (54)

1. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:265-71.
2. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-5.
3. Ford D, Easton DF. The genetics of breast and ovarian cancer, Br J Cancer 1995;72:805-12.
4. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993;52:678-701.
5. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2, Cancer Genetics Study Consortium. JAMA 1997;277:997-1003.
6. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
7. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst 1997;89(14):1015-26.
8. Iselius L, Wilking N. Screening for familial cancer. In: Weber W, Mulvihill JJ, Narod S, editors. Familial cancer management. New York: CRC Press, 19XX:75-6.
9. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
10. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human solid neoplasms: part I. J Surg Oncol 1995;60:137-46.
11. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human neoplasms: Part II. J Surg Oncol 1996;61:68-83.
12. Foulkes WD, Wong N, Brunet JS, Begin LR, Zhang JC, Martinez JJ, et al. Germ-line mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 1997;3:2465-9.
13. Verhoog LC, Brekelmans CTM, Seynaeve C, van den Bosch LMC, Dahmen G, van Geel AN, et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998;351:316-21.
14. Johannsson OT, Ranstam J, Borg A, Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 1998;16: 397-404.
15. Crook T, Crossland S, Crompton MR, Osin P, Gusterson BA. p53 mutations in BRCA1-associated familial breast cancer [letter]. Lancet 1997;350(9078):638-9.
16. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 1997;349(9064):1505-10.
17. Lerman C. Few BRCA1 carriers take recommended precautions. Oncol News 1998;7(2):1.
18. Smart CR, Byrne C, Smith RA, Garfinkel L, Letton AH, Dodd GD, et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997;47(3):134-49.
19. Holleb AI, Montgomery R, Farrow JH. The hazard of incomplete simple mastectomy. Surg Gynecol Obstet 1965;121:819-22.
20. Ziegler LD, Kroll SS. Primary breast cancer after prophylactic mastectomy. Am I Clin Oncol 1991;14:451-4.
21. Goodnight JE Jr., Quagliana JM, Morton DL. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 1984;26:198-201.
22. Bowers DG Jr., Radlauer CB. Breast cancer after prophylactic subcutaneous mastectomies and reconstruction with silastic prostheses. Plast Reconstr Surg 1969;44:541-4.
23. Mendez-Fernandez MA, Henly WS, Geis RC, Schoen FJ, Hausner RJ. Paget's disease of the breast after subcutaneous mastectomy and reconstruction with a silicone prosthesis. Plast Reconstr Surg 1980;65(5):683-5.
24. Eldar S, Meguid MM, Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg 1984; 148:692-3.
25. Jameson MB, Roberts E, Nixon J, Probert JC, Braatvedt GD. Metastatic breast cancer 42 years after bilateral subcutaneous mastectomies. Clin Oncol (R Coll Radiol) 1997;9(2):119-21.
26. Humphrey LJ. Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: opinion or knowledge? Am J Surg 1983;145:311-21.
27. Pennisi VR, Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg 1989;13:15-21.
28. Woods JE, Meland NB. Conservative management in full-thickness nipple-areolar necrosis after subcutaneous mastectomy. Plast Reconstr Surg 1989;84:258-66.
29. Slade CL. Subcutaneous mastectomy: acute complications and long-term follow-up. Plast Reconstr Surg 1984;73(1):84-90.
30. Fredericks S. A 10-year experience with subcutaneous mastectomy. Clin Plast Surg 1975;2:347-57.
31. Amaaki T, Yasumura K, Kami T, Tahara H. Prophylactic subcutaneous total glandectomy for mammary cystic disease, with immediate primary breast reconstruction. Ann Plast Surg 1979;3:420-4.
32. Hartmann L, Jenkins R, Schaid D, et al. Prophylactic mastectomy (PM): preliminary retrospective cohort analysis. Proc Am Assoc Cancer Res 1997;38:168.
33. Mackarem G, Roche CA, Silverman ML, Hughes KS. Brief clinical report: the development of new, primary noninvasive carcinoma of the breast 29 years after bilateral radical mastectomy. Breast J. 1998;4:51-4.
34. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT, Melton LJ III. Complications leading to surgery after breast implantation. N Engl J Med 1997;336:677-82.
35. Bostwick J III. Breast reconstruction following mastectomy. CA Cancer J Clin 1995;45:289-304.
36. Horton CE, Dascombe WH. Total mastectomy: indications and techniques. Clin Plast Surg 1988;15:677-87.
37. Jarrett JR. Prophylactic mastectomy. In: Marsh JL, Decker BC, editors. Current therapy in plastic and reconstructive surgery. Toronto:,1989:64-70.
38. Jarrett JR, Cutler RG, Teal DF. Aesthetic refinements in prophylactic subcutaneous mastectomy with submuscular reconstruction. Plast Reconstr Surg 1982;69:624-31.
39. Bostwick J III, Jones G. Why I choose autogenous tissue in breast reconstruction. Clin Plast Surg 1994;21:165-75.
40. Elliott LF. Options for donor sites for autogenous tissue breast reconstruction. Clin Plast Surg 1994;21:177-89.
41. Hartrampf CR, Scheflan M, Black PW. Breast reconstruction with a transverse abdominal island flap. Plast Reconstr Surg 1982;69:216-25.
42. Beasley ME. The pedicled TRAM as preference for immediate autogenous tissue breast reconstruction. Clin Plast Surg 1994;21:191-205.
43. Schusterman MA, Kroll SS, Miller MJ, Reece GP, Baldwin BJ, Robb GL, et al. The free transverse rectus abdominis musculocutaneous flap for breast reconstruction: one center's experience with 211 consecutive cases. Ann Plast Surg 1994; 32:234-41.
44. Watterson PA, Bostwick J III, Hester TR Jr., Bried JT, Taylor GI. TRAM flap anatomy correlated with a 10-year clinical experience with 556 patients. Plast Reconstr Surg 1995;95: 1185-94.
45. Leibman AJ, Styblo TM, Bostwick J III. Mammography of the postreconstruction breast. Plast Reconstr Surg 1997;99:698-704.
46. Noone RB, Frazier TG, Noone GC, Blanchet NP, Murphy JB, Rose D. Recurrence of breast carcinoma following immediate reconstruction: a 13-year review. Plast Reconstr Surg 1994;93:96-106.
47. Slavin SA, Love SM, Goldwyn RM. Recurrent breast cancer following immediate reconstruction with myocutaneous flaps. Plast Reconstr Surg 1994;93:1191-204.
48. Yamamoto Y, Nohira K, Sugihara T, Shintomi Y, Ohura T. Superiority of the microvascularly augmented flap: analysis of 50 transverse rectus abdominis myocutaneous flaps for breast reconstruction. Plast Reconstr Surg 1996;97:79-83.
49. Grotting JC, Urist MM, Maddox WA, Vasconez LO. Conventional TRAM flap versus free microsurgical TRAM flap for immediate breast reconstruction. Plast Reconstr Surg 1989; 83:828-41.
50. Banic A, Boeckx W, Greulich M, Guelickx P, Marchi A, Rigotti G. Late results of breast reconstruction with free TRAM flaps: a prospective multicentric study. Plast Reconstr Surg 1995;95:1195-204.
51. Kroll SS. Invited discussion [discussion]. Plast Reconstr Surg 1995;95:1205-6. Discussion on: Plast Reconstr Surg 1995;95: 195-204.
52. Kroll SS. Invited discussion [discussion]. Plast Reconstr Surg 1995;95:1205-6. Discussion on: Plast Reconstr Surg 1995;95: 195-204.
53. Shaw W. Invited discussion [discussion]. Ann Plast Surg 1994; 32:241-2. Discussion on: Ann Plast Surg 1994;32:234-41.
54. Shaw W. Invited discussion [discussion]. Ann Plast Surg 1994; 32:241-2. Discussion on: Ann Plast Surg 1994;32:234-41.